Eighth Annual Structural Heart Intervention and Imaging

Eighth Annual Structural Heart Intervention and Imaging is organized by Scripps Health and will be held from Feb 06 - 08, 2019 at Hyatt Regency La Jolla at Aventine, San Diego, California, United States of America.

Target Audience :
• Interventional Cardiologists.
• Invasive Cardiologists.
• Echocardiographers.
• Interventional Radiologists.
• Cardiovascular Surgeons.
• Cardiac Anesthesiologists. 
• Cardiology Nurses and Physician Assistants.
• Cardiovascular Sonographers.
• Cardiac Catheterization Technicians.

Accreditation :
Physicians: This live activity for a maximum of 17.5 AMA PRA Category 1 Credits
Physician Assistants: PAs may claim a maximum of 17.5 Category 1 credits for completing this activity.

Conference Description :
This conference is designed to provide a practical, cutting-edge, and case-based assessment of the emerging area of structural heart disease intervention and interventional cardiovascular imaging, with an emphasis on the collaborative nature of these procedures across many disciplines within cardiology. The expert faculty will include interventionists, invasive cardiologists, echocardiographers, electrophysiologists, cardiac surgeons, anesthesiologists, and sonographers. Faculty will discuss clinical guidelines on patient selection, pre-procedural assessment, procedural tips, techniques and challenges (including concurrent imaging) during the performance of the procedures and conclude with assessment of outcomes and future directions.

Conference Objectives are :
• Assemble the appropriate multidisciplinary team, imaging technologies and catheter equipment to perform structural heart disease interventions.
• Identify complications of catheter-based therapies for structural heart disease and safely manage them with various procedural techniques.
• Apply a comprehensive approach to the assessment of the aortic, mitral, and tricuspid valves, and the interatrial septum, using echocardiography (TTE, TEE and ICE), CT, and MRI for the purpose of the interventional treatment of these cardiac structures.
• Interpret current clinical data in order to optimize the treatment of patients with aortic stenosis, mitral regurgitation and atrial fibrillation.
• Discuss tricuspid anatomy and function and assess the implications of tricuspid regurgitation and transcatheter techniques for transcatheter tricuspid valve repair.
• Cite the current indications for catheter-based techniques, including transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair/replacement, left atrial appendage closure, ASD, and paravalvular leaks.
• Evaluate the patient with cryptogenic stroke and identify the patient in whom PFO closure is appropriate.
• Integrate emerging data into TAVR decision-making regarding surgical risk, including low and intermediate-risk patients.
• Interpret and incorporate CT imaging before and after LAA closure.
• Integrate basic and advanced imaging and catheter techniques for transseptal puncture for the purpose of LAA closure, transcatheter mitral valve repair and paravalvular leak closure.
• Select the appropriate type and size device for TAVR, LAA closure, PFO closure, and other structural interventions.
• Apply echocardiographic findings to determine optimal strategy for transcatheter mitral valve repair.
• Employ specific catheter techniques and technologies for the transcatheter repair of simple and complex aortic and mitral paravalvular leaks.
• Incorporate advanced techniques for transcatheter mitral valve repair, TAVR, PFO, ASD, and LAA closure in the setting of challenging anatomy and/or patient co-morbidities.
• Avoid common pitfalls in the application of the newer imaging modalities.

Speakers: Matthew J. Price, MD, FACC, Scripps Clinic and Prebys Cardiovascular Institute, Jason H. Rogers, MD, FACC, FSCAI, University of California, Davis Medical Center, David S. Rubenson, MD, FACC, FASE, Scripps Clinic and Prebys Cardiovascular Institute, Jamil A. Aboulhosn, MD, FACC, University of California, Los Angeles, Philippe Genereux, MD, Atlantic Health System, Mayra E. Guerrero, MD, FACC, FSCAI, Mayo Clinic, Rebecca T. Hahn, MD, FASE, FACC, Columbia University Medical Center / New York-Presbyterian Hospital, Saibal Kar, MD, FAHA, FACC, FSCAI, Cedars-Sinai Medical Center, G. Burkhard Mackensen, MD, PhD, FASE, University of Washington Medical Center, Michael H. Picard, MD, FACC, FASE, Massachusetts General Hospital, Michael J. Reardon, MD, Houston Methodist Hospital, Mark D. Reisman, MD, FACC, University of Washington Medical Center, David G. Rizik, MD, FACC, FSCAI, HonorHealth Heart Group, Jacqueline Saw, MD, FRCPC, FACC, FAHA, FSCAI, Vancouver General Hospital, Douglas C. Shook, MD, FASE, Brigham and Women's Hospital , Gagan D. Singh, MD, MS, University of California, Davis Medical Center, Thomas W.R. Smith, MD, FACC, University of California, Davis Medical Center, William J. Stewart, MD, FACC, FASE, Cleveland Clinic, Gilbert H. Tang, MD, MSc, MBA, FRCSC, FACC, Mount Sinai Health System, Paul S. Teirstein, MD, FACC, FSCAI, Scripps Clinic and Prebys Cardiovascular Institute

Time: 7:00 am to 12:00 pm